ADI Valuation Metrics
ADI Stock Price Metrics
ADI Dividend Metrics
ADI Growth Rate Metrics
ADI Discounted Cash Flow Metrics
| Fair Value Price | $199.06 |
| Margin of Safety | (49.48%) |
ADI Revenue Metrics
ADI PE Ratio Metrics
| PE Ratio | 58.55 |
| PE Ratio Avg TTM | 63.49 |
| PE Ratio Avg 3Y | 52.33 |
| Current VS TTM Avg | -7.79% |
| Current VS 3Y Avg | +11.89% |
| Current VS 5Y Avg | +24.06% |
ADI PS Ratio Metrics
| PS Ratio | 15.17 |
| PS Ratio Avg TTM | 13.07 |
| PS Ratio Avg 3Y | 10.71 |
| Current VS TTM Avg | +16.07% |
| Current VS 3Y Avg | +41.71% |
| Current VS 5Y Avg | +52.32% |
ADI PB Ratio Metrics
| PB Ratio | 5.73 |
| PB Ratio Avg TTM | 4.22 |
| PB Ratio Avg 3Y | 3.33 |
| Current VS TTM Avg | +35.77% |
| Current VS 3Y Avg | +72.04% |
| Current VS 5Y Avg | +78.69% |
ADI Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 42.33 |
| PFCF Ratio Avg TTM | 35.58 |
| PFCF Ratio Avg 3Y | 32.63 |
| Current VS TTM Avg | +18.97% |
| Current VS 3Y Avg | +29.73% |
| Current VS 5Y Avg | +40.28% |
ADI Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.26 |
| Debt/Equity Ratio Avg TTM | 0.24 |
| Debt/Equity Ratio Avg 3Y | 0.23 |
| Current VS TTM Avg | +8.33% |
| Current VS 3Y Avg | +14.71% |
| Current VS 5Y Avg | +25.00% |
ADI PEG Ratio Metrics
| PEG Ratio | 1.31 |
| PEG Ratio Avg TTM | 1.31 |
| PEG Ratio Avg 3Y | 1.31 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
ADI FCF Yield
| FCF Yield | 2.36% |
| FCF Yield Avg TTM | 2.84% |
| FCF Yield Avg 3Y | 3.15% |
| Current VS TTM Avg | -16.98% |
| Current VS 3Y Avg | -25.17% |
| Current VS 5Y Avg | -31.45% |
ADI Earnings Yield
| Earnings Yield | 1.71% |
| Earnings Yield Avg TTM | 1.58% |
| Earnings Yield Avg 3Y | 2.21% |
| Current VS TTM Avg | +8.02% |
| Current VS 3Y Avg | -22.78% |
| Current VS 5Y Avg | -28.18% |
ADI EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 48.19 |
| Ev/Ebit Ratio Avg TTM | 51.70 |
| Ev/Ebit Ratio Avg 3Y | 44.28 |
| Current VS TTM Avg | -6.79% |
| Current VS 3Y Avg | +8.83% |
| Current VS 5Y Avg | +15.43% |
ADI EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 32.21 |
| Ev/Ebitda Ratio Avg TTM | 29.65 |
| Ev/Ebitda Ratio Avg 3Y | 24.30 |
| Current VS TTM Avg | +8.63% |
| Current VS 3Y Avg | +32.56% |
| Current VS 5Y Avg | +35.22% |
ADI EV/Assets Ratio Metrics
| Ev/Assets Ratio | 4.16 |
| Ev/Assets Ratio Avg TTM | 3.12 |
| Ev/Assets Ratio Avg 3Y | 2.52 |
| Current VS TTM Avg | +33.33% |
| Current VS 3Y Avg | +65.12% |
| Current VS 5Y Avg | +76.75% |
ADI EV/Sales Ratio Metrics
| Ev/Sales Ratio | 15.66 |
| Ev/Sales Ratio Avg TTM | 13.61 |
| Ev/Sales Ratio Avg 3Y | 11.24 |
| Current VS TTM Avg | +15.08% |
| Current VS 3Y Avg | +39.34% |
| Current VS 5Y Avg | +49.44% |
ADI Current Ratio Metrics
| Current Ratio | 2.19 |
| Current Ratio Avg TTM | 2.02 |
| Current Ratio Avg 3Y | 1.80 |
| Current VS TTM Avg | +8.68% |
| Current VS 3Y Avg | +21.67% |
| Current VS 5Y Avg | +16.99% |
ADI Quick Ratio Metrics
| Quick Ratio | 1.68 |
| Quick Ratio Avg TTM | 1.52 |
| Quick Ratio Avg 3Y | 1.30 |
| Current VS TTM Avg | +10.89% |
| Current VS 3Y Avg | +29.56% |
| Current VS 5Y Avg | +22.63% |
ADI ROIC Metrics
| ROIC | 5.42% |
| ROIC Avg 3Y | 5.66% |
| ROIC Avg 5Y | 5.29% |
| Current VS 3Y Avg | -4.24% |
| Current VS 5Y Avg | +2.53% |
| Current VS 10Y Avg | -20.22% |
ADI Return on Assets Metrics
| ROA | 4.72 |
| ROA Avg TTM | 4.05 |
| ROA Avg 3Y | 4.97 |
| Current VS TTM Avg | +16.40% |
| Current VS 3Y Avg | -4.97% |
| Current VS 5Y Avg | +2.52% |
ADI Return on Equity Metrics
| ROE | 6.70 |
| ROE Avg TTM | 5.68 |
| ROE Avg 3Y | 6.89 |
| Current VS TTM Avg | +18.06% |
| Current VS 3Y Avg | -2.76% |
| Current VS 5Y Avg | +5.11% |
ADI Net Profit Margin Metrics
| Net Profit Margin | 20.58% |
| Net Profit Margin Avg TTM | 18.96% |
| Net Profit Margin Avg 3Y | 21.62% |
| Current VS TTM Avg | +8.52% |
| Current VS 3Y Avg | -4.83% |
| Current VS 5Y Avg | -3.61% |
Last Updated: Wednesday, June 10, 2026
About Analog Devices, Inc.
Analog Devices, Inc. (ADI) is a technology leader specializing in the conception, production, validation, and global marketing of integrated circuits (ICs), software solutions, and advanced subsystems. Their offerings leverage sophisticated analog, mixed-signal, and digital signal processing technologies. The company's comprehensive product lineup features data converters, which are critical for transforming real-world analog signals into digital data and subsequently converting digital data back into analog signals. They also provide power management and reference devices, essential for power conversion, driver supervision, system sequencing, and energy optimization in industries such as automotive, telecommunications, industrial applications, and premium consumer markets. These power ICs are supported by integrated performance, integration, and software design simulation tools for precise power supply development. ADI's portfolio further includes high-performance amplifiers, designed for conditioning analog signals, as well as radio frequency (RF) and microwave ICs that underpin cellular infrastructure. They also develop microelectromechanical systems (MEMS) technology, encompassing accelerometers for sensing acceleration, gyroscopes for measuring rotation, inertial measurement units (IMUs) for detecting multi-axis movement, broadband switches for radio and instrumentation systems, and isolators. Moreover, the company supplies digital signal processing (DSP) and system products engineered for rapid numeric calculations. Serving a wide array of clients across the industrial, automotive, consumer, instrumentation, aerospace, and communications sectors, Analog Devices distributes its products globally. This is accomplished via a multifaceted approach, including a direct sales force, authorized third-party distributors, independent sales representatives throughout the United States, the Americas, Europe, Japan, China, and other regions of Asia, in addition to its online platform. Analog Devices, Inc. was founded in 1965 and is headquartered in Wilmington, Massachusetts.
- Sector
- Technology
- Industry
- Semiconductors
- CEO
- Vincent T. Roche